2 recruiting, 1 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 2, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Aspirin 162 mg: new trials by email Literature Review of Aspirin 162 mg trials Research Report on Aspirin 162 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia Aspirin 162 mg, Aspirin 81mg - Pre-Eclampsia, Pregnancy Loss | Phase 3 | Recruiting | University of Pennsylvania | 1150 | 2024-06-12 | 2026-09-10 |
| Trial to Determine Effective Aspirin Dose in COPD Aspirin 81mg, Aspirin 162 mg, Aspirin 325mg - Pulmonary Disease, Chronic Obstructive | Phase 3 | Recruiting | Johns Hopkins University | 48 | 2023-05-16 | 2026-03-16 |
| Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida Aspirin 81 mg, Aspirin 162 mg - Pre-Eclampsia, Hypertension in Pregnancy | Phase 2 / Phase 3 | Completed | The University of Texas Health Science Center, Houston | 220 | 2019-05-06 | 2024-05-08 |
Pre-Eclampsia (2) · Hypertension, Pregnancy-Induced (1) · Obesity (1) · Pulmonary Disease, Chronic Obstructive (1)
Johns Hopkins University (1) · The University of Texas Health Science Center, Houston (1) · University of Pennsylvania (1)
United States (3)
Ashraf Fawzy, MD, MPH (1) · Enrique Schisterman, PhD (1) · Kurt Barnhart, MD (1)
K23HL151758 (1), R01HD112308 (1)